BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31799477)

  • 1. Intestinal-level anti-inflammatory bioactivities of catechin-rich green tea: Rationale, design, and methods of a double-blind, randomized, placebo-controlled crossover trial in metabolic syndrome and healthy adults.
    Hodges JK; Zhu J; Yu Z; Vodovotz Y; Brock G; Sasaki GY; Dey P; Bruno RS
    Contemp Clin Trials Commun; 2020 Mar; 17():100495. PubMed ID: 31799477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A green tea extract confection decreases circulating endotoxin and fasting glucose by improving gut barrier function but without affecting systemic inflammation: A double-blind, placebo-controlled randomized trial in healthy adults and adults with metabolic syndrome.
    Zeng M; Hodges JK; Pokala A; Khalafi M; Sasaki GY; Pierson J; Cao S; Brock G; Yu Z; Zhu J; Vodovotz Y; Bruno RS
    Nutr Res; 2024 Apr; 124():94-110. PubMed ID: 38430822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation.
    Dey P; Sasaki GY; Wei P; Li J; Wang L; Zhu J; McTigue D; Yu Z; Bruno RS
    J Nutr Biochem; 2019 May; 67():78-89. PubMed ID: 30856467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota.
    Dey P; Olmstead BD; Sasaki GY; Vodovotz Y; Yu Z; Bruno RS
    J Nutr Biochem; 2020 Oct; 84():108455. PubMed ID: 32688217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies.
    Hodges JK; Sasaki GY; Bruno RS
    J Nutr Biochem; 2020 Nov; 85():108478. PubMed ID: 32801031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green Tea Extract Treatment in Obese Mice with Nonalcoholic Steatohepatitis Restores the Hepatic Metabolome in Association with Limiting Endotoxemia-TLR4-NFκB-Mediated Inflammation.
    Sasaki GY; Li J; Cichon MJ; Riedl KM; Kopec RE; Bruno RS
    Mol Nutr Food Res; 2019 Dec; 63(24):e1900811. PubMed ID: 31574193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleviation of Metabolic Endotoxemia by Milk Fat Globule Membrane: Rationale, Design, and Methods of a Double-Blind, Randomized, Controlled, Crossover Dietary Intervention in Adults with Metabolic Syndrome.
    Quarles WR; Pokala A; Shaw EL; Ortega-Anaya J; Hillmann L; Jimenez-Flores R; Bruno RS
    Curr Dev Nutr; 2020 Sep; 4(9):nzaa130. PubMed ID: 32885133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea extract alters gut microbiota and their metabolism of adults with metabolic syndrome in a host-free human colonic model.
    Zhang S; Xu M; Sun X; Shi H; Zhu J
    Food Res Int; 2022 Oct; 160():111762. PubMed ID: 36076430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
    Li J; Sasaki GY; Dey P; Chitchumroonchokchai C; Labyk AN; McDonald JD; Kim JB; Bruno RS
    J Nutr Biochem; 2018 Mar; 53():58-65. PubMed ID: 29190550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechin Bioavailability Following Consumption of a Green Tea Extract Confection Is Reduced in Obese Persons without Affecting Gut Microbial-Derived Valerolactones.
    Sasaki GY; Vodovotz Y; Yu Z; Bruno RS
    Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intestinal-level metabolic benefits of green tea catechins: Mechanistic insights from pre-clinical and clinical studies.
    Sidhu D; Vasundhara M; Dey P
    Phytomedicine; 2024 Jan; 123():155207. PubMed ID: 38000106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A green tea-containing starch confection increases plasma catechins without protecting against postprandial impairments in vascular function in normoglycemic adults.
    Sapper TN; Mah E; Ahn-Jarvis J; McDonald JD; Chitchumroonchokchai C; Reverri EJ; Vodovotz Y; Bruno RS
    Food Funct; 2016 Sep; 7(9):3843-53. PubMed ID: 27494176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome.
    Guevara-Cruz M; Flores-López AG; Aguilar-López M; Sánchez-Tapia M; Medina-Vera I; Díaz D; Tovar AR; Torres N
    J Am Heart Assoc; 2019 Sep; 8(17):e012401. PubMed ID: 31451009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milk-Fat-Globule-Membrane-Enriched Dairy Milk Compared with a Soy-Lecithin-Enriched Beverage Did Not Adversely Affect Endotoxemia or Biomarkers of Gut Barrier Function and Cardiometabolic Risk in Adults with Metabolic Syndrome: A Randomized Controlled Crossover Trial.
    Pokala A; Quarles WR; Ortega-Anaya J; Jimenez-Flores R; Cao S; Zeng M; Hodges JK; Bruno RS
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechin-Rich Green Tea Extract and the Loss-of-TLR4 Signaling Differentially Alter the Hepatic Metabolome in Mice with Nonalcoholic Steatohepatitis.
    Sasaki GY; Li J; Cichon MJ; Kopec RE; Bruno RS
    Mol Nutr Food Res; 2021 Jan; 65(2):e2000998. PubMed ID: 33249742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the Diversity and Metabolic Shift of Gut Microbes during Green Tea Feeding in an In Vitro Human Colonic Model.
    Xu M; Yang K; Zhu J
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33153091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: a randomized double-blind controlled clinical trial.
    Lee SJ; Bose S; Seo JG; Chung WS; Lim CY; Kim H
    Clin Nutr; 2014 Dec; 33(6):973-81. PubMed ID: 24411490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.
    Suzuki-Sugihara N; Kishimoto Y; Saita E; Taguchi C; Kobayashi M; Ichitani M; Ukawa Y; Sagesaka YM; Suzuki E; Kondo K
    Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial.
    Hsu CH; Liao YL; Lin SC; Tsai TH; Huang CJ; Chou P
    Altern Med Rev; 2011 Jun; 16(2):157-63. PubMed ID: 21649457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isomalto-oligosaccharides, a prebiotic, functionally augment green tea effects against high fat diet-induced metabolic alterations via preventing gut dysbacteriosis in mice.
    Singh DP; Singh J; Boparai RK; Zhu J; Mantri S; Khare P; Khardori R; Kondepudi KK; Chopra K; Bishnoi M
    Pharmacol Res; 2017 Sep; 123():103-113. PubMed ID: 28668709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.